Mycophenolate Mofetil Placebo

DRUG2 trials

Sponsors

Hoffmann-La Roche, LMU Klinikum

Conditions

Inflammatory CardiomyopathyPemphigus Vulgaris

Phase 2

Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy

TerminatedNCT05570409

LMU KlinikumInflammatory Cardiomyopathy

Start: 2023-03-28End: 2025-04-14Updated: 2025-07-25

Phase 3

A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV)

CompletedNCT02383589

Hoffmann-La RochePemphigus Vulgaris

Start: 2015-05-26End: 2019-10-29Updated: 2020-11-10

Related Papers

Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris

New England Journal of Medicine2021-05-19108 citations